What is the share price of Alembic Ltd (ALEMBICLTD) today?
The share price of ALEMBICLTD as on 5th December 2025 is ₹101.67. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Alembic Ltd (ALEMBICLTD) share?
The past returns of Alembic Ltd (ALEMBICLTD) share are- Past 1 week: 3.22%
- Past 1 month: 0.71%
- Past 3 months: -1.31%
- Past 6 months: -7.16%
- Past 1 year: -25.03%
- Past 3 years: 34.92%
- Past 5 years: -1.45%
What are the peers or stocks similar to Alembic Ltd (ALEMBICLTD)?
The peers or stocks similar to Alembic Ltd (ALEMBICLTD) include:What is the dividend yield % of Alembic Ltd (ALEMBICLTD) share?
The current dividend yield of Alembic Ltd (ALEMBICLTD) is 2.34.What is the market cap of Alembic Ltd (ALEMBICLTD) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Alembic Ltd (ALEMBICLTD) is ₹2638.18 Cr as of 5th December 2025.What is the 52 week high and low of Alembic Ltd (ALEMBICLTD) share?
The 52-week high of Alembic Ltd (ALEMBICLTD) is ₹153.39 and the 52-week low is ₹85.46.What is the PE and PB ratio of Alembic Ltd (ALEMBICLTD) stock?
The P/E (price-to-earnings) ratio of Alembic Ltd (ALEMBICLTD) is 8.49. The P/B (price-to-book) ratio is 1.13.Which sector does Alembic Ltd (ALEMBICLTD) belong to?
Alembic Ltd (ALEMBICLTD) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy Alembic Ltd (ALEMBICLTD) shares?
You can directly buy Alembic Ltd (ALEMBICLTD) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Alembic Ltd
ALEMBICLTD Share Price
101.671.04% (-1.07)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
ALEMBICLTD Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
AvgCan be considered moderately valued vs the market
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
GoodThe stock is underpriced and is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
ALEMBICLTD Performance & Key Metrics
ALEMBICLTD Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 8.14 | 1.13 | 2.34% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 36.94 | 5.83 | 0.58% |
ALEMBICLTD Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
ALEMBICLTD Company Profile
Alembic Limited is engaged in the business of pharmaceuticals, real estate and power assets. The Company's segments include API and Real Estate.
SUNPHARMA
PE Ratio
39.92
39.92
1Y Return
1.01%
1.01%
Buy Reco %
91.67
91.67
TORNTPHARM
PE Ratio
67.21
67.21
1Y Return
13.21%
13.21%
Buy Reco %
76.92
76.92
CIPLA
PE Ratio
23.30
23.30
1Y Return
1.34%
1.34%
Buy Reco %
70.00
70.00
DRREDDY
PE Ratio
18.81
18.81
1Y Return
5.10%
5.10%
Buy Reco %
41.94
41.94
LUPIN
PE Ratio
29.12
29.12
1Y Return
0.46%
0.46%
Buy Reco %
72.22
72.22
ALEMBICLTD Forecast
ALEMBICLTD Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
ALEMBICLTD
ALEMBICLTD
Income
Balance Sheet
Cash Flow
Annual Normal View
ALEMBICLTD Income Statement
ALEMBICLTD Income Statement
Annual Normal View
| Financial Year | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 178.13 | 162.32 | 153.26 | 167.33 | 83.79 | 167.40 | 191.50 | 212.26 | 296.78 | 299.64 | ||||||||||
Raw Materials | 50.97 | 39.86 | 45.21 | 24.59 | 11.77 | 8.53 | 6.92 | 8.62 | 8.00 | 127.24 | ||||||||||
| Power & Fuel Cost | 5.46 | 1.11 | 2.34 | 0.91 | 0.42 | 0.15 | 2.02 | 1.18 | 2.34 | |||||||||||
| Employee Cost | 28.64 | 19.64 | 20.52 | 20.79 | 22.60 | 21.47 | 24.04 | 23.03 | 27.31 | |||||||||||
| Selling & Administrative Expenses | 7.38 | 7.13 | 7.26 | 9.17 | 7.56 | 9.82 | 10.81 | 14.04 | 14.08 | |||||||||||
| Operating & Other expenses | 53.80 | 46.45 | 30.41 | 15.19 | 20.10 | 24.33 | 53.73 | 53.76 | 76.44 | |||||||||||
EBITDA | 31.88 | 48.13 | 47.52 | 96.68 | 21.34 | 103.10 | 93.98 | 111.63 | 168.61 | 172.40 | ||||||||||
| Depreciation/Amortization | 5.09 | 3.78 | 2.63 | 3.23 | 3.94 | 4.86 | 6.72 | 7.84 | 10.63 | 11.05 | ||||||||||
| PBIT | 26.79 | 44.35 | 44.89 | 93.45 | 17.40 | 98.24 | 87.26 | 103.79 | 157.98 | 161.35 | ||||||||||
| Interest & Other Items | 0.16 | 0.17 | 0.22 | 0.29 | 0.36 | 0.39 | 0.47 | 1.11 | 2.47 | 2.46 | ||||||||||
| PBT | 26.63 | 44.18 | 44.67 | 93.16 | 17.04 | 97.85 | 86.79 | 102.68 | 155.51 | 158.89 | ||||||||||
| Taxes & Other Items | -118.75 | -118.81 | -168.43 | -235.95 | -325.80 | -124.20 | -103.85 | -165.93 | -155.17 | -165.08 | ||||||||||
| Net Income | 145.38 | 162.99 | 213.10 | 329.11 | 342.84 | 222.05 | 190.64 | 268.61 | 310.68 | 323.97 | ||||||||||
| EPS | 4.43 | 4.97 | 6.62 | 11.50 | 13.35 | 8.65 | 7.42 | 10.46 | 12.10 | 12.62 | ||||||||||
| DPS | 0.16 | 0.16 | 0.16 | 0.60 | 0.20 | 1.80 | 2.20 | 2.40 | 2.40 | 2.40 | ||||||||||
| Payout ratio | 0.04 | 0.03 | 0.02 | 0.05 | 0.01 | 0.21 | 0.30 | 0.23 | 0.20 | 0.19 |
ALEMBICLTD Company Updates
ALEMBICLTD Stock Peers
ALEMBICLTD Past Performance & Peer Comparison
ALEMBICLTD Past Performance & Peer Comparison
Comparing 3 stocks from
Health CarePharmaceuticals
Compare valuation on Screener
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Alembic Ltd | 8.49 | 1.13 | 2.34% |
| Sun Pharmaceutical Industries Ltd | 39.92 | 6.02 | 0.88% |
| Torrent Pharmaceuticals Ltd | 67.21 | 16.92 | 0.84% |
| Cipla Ltd | 23.30 | 3.93 | 1.05% |
ALEMBICLTD Stock Price Comparison
Compare ALEMBICLTD with any stock or ETFCompare ALEMBICLTD with any stock or ETF
ALEMBICLTD
ALEMBICLTD Holdings
ALEMBICLTD Shareholdings
ALEMBICLTD Promoter Holdings Trend
ALEMBICLTD Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
ALEMBICLTD Institutional Holdings Trend
ALEMBICLTD Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
ALEMBICLTD Shareholding Pattern
ALEMBICLTD Shareholding Pattern
ALEMBICLTD Shareholding History
ALEMBICLTD Shareholding History
Foreign Institutions
Mutual Funds Invested in ALEMBICLTD
Mutual Funds Invested in ALEMBICLTD
No mutual funds holding trends are available
Top 1 Mutual Funds holding Alembic Ltd
| Funds (Top 1) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 0.0001% | Percentage of the fund’s portfolio invested in the stock 0.00% | Change in the portfolio weight of the stock over the last 3 months -0.00% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 823/1023 (+82) |
Compare 3-month MF holding change on Screener
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases containing ALEMBICLTD stock
smallcases containing ALEMBICLTD stock
Looks like this stock is not in any smallcase yet.
ALEMBICLTD Events
ALEMBICLTD Events
ALEMBICLTD Dividend Trend
No Dividend Cuts
Dividends are the portion of earnings that a company distributes to all its shareholders every year
ALEMBICLTD has increased or maintained dividend levels over the last 5 years
Dividend Yield
Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation
Current dividend yield is 2.34%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹23.36 every year
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
ALEMBICLTD Dividend Trend
No Dividend Cuts
Dividends are the portion of earnings that a company distributes to all its shareholders every year
ALEMBICLTD has increased or maintained dividend levels over the last 5 years
Dividend Yield
Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation
Current dividend yield is 2.34%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹23.36 every year
ALEMBICLTD Upcoming Dividends
ALEMBICLTD Upcoming Dividends
No upcoming dividends are available
ALEMBICLTD Past Dividends
ALEMBICLTD Past Dividends
Cash Dividend
Ex DateEx DateAug 5, 2025
Final
Final | Div/Share: ₹2.40
Dividend/Share
₹2.40
Ex DateEx Date
Aug 5, 2025
Cash Dividend
Ex DateEx DateAug 5, 2024
Final
Final | Div/Share: ₹2.40
Dividend/Share
₹2.40
Ex DateEx Date
Aug 5, 2024
Cash Dividend
Ex DateEx DateAug 3, 2023
Final
Final | Div/Share: ₹2.20
Dividend/Share
₹2.20
Ex DateEx Date
Aug 3, 2023
Cash Dividend
Ex DateEx DateSep 12, 2022
Final
Final | Div/Share: ₹1.80
Dividend/Share
₹1.80
Ex DateEx Date
Sep 12, 2022
Cash Dividend
Ex DateEx DateJul 29, 2021
Final
Final | Div/Share: ₹0.20
Dividend/Share
₹0.20
Ex DateEx Date
Jul 29, 2021
ALEMBICLTD Stock News & Opinions
ALEMBICLTD Stock News & Opinions
Articles & Videos
Earnings
Alembic consolidated net profit rises 6.17% in the September 2025 quarter
Net profit of Alembic rose 6.17% to Rs 128.49 crore in the quarter ended September 2025 as against Rs 121.02 crore during the previous quarter ended September 2024. Sales rose 5.58% to Rs 55.86 crore in the quarter ended September 2025 as against Rs 52.91 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales55.8652.91 6 OPM %41.6037.01 - PBDT87.6084.51 4 PBT84.7881.83 4 NP128.49121.02 6 Powered by Capital Market - Live
3 weeks agoCapital Market - Live
Corporate
Alembic to conduct board meeting
Alembic will hold a meeting of the Board of Directors of the Company on 10 November 2025.Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Alembic announces change in directorate
The Board of Alembic at its meeting held on 12 August 2025 noted the following change in directorate: Appointment of Udit Amin (DIN: 00244235), currently serving as Non-Executive Non-Independent Director, as Managing Director (KMP) of the Company for a period of 5 (five) years w.e.f. 1 October 2025. Resignation of Malika Amin (DIN: 00242613) from the position of Managing Director & CEO of the Company w.e.f. 01 January 2026. She will continue serving the Board as Non-Executive Director, liable to retire by rotation. Powered by Capital Market - Live
3 months agoCapital Market - Live
Earnings
Alembic consolidated net profit rises 10.43% in the June 2025 quarter
Net profit of Alembic rose 10.43% to Rs 61.64 crore in the quarter ended June 2025 as against Rs 55.82 crore during the previous quarter ended June 2024. Sales declined 2.03% to Rs 49.75 crore in the quarter ended June 2025 as against Rs 50.78 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales49.7550.78 -2 OPM %39.3840.17 - PBDT22.5921.87 3 PBT19.8019.37 2 NP61.6455.82 10 Powered by Capital Market - Live
3 months agoCapital Market - Live
Corporate
Alembic to discuss results
Alembic will hold a meeting of the Board of Directors of the Company on 12 August 2025.Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Alembic to convene AGM
Alembic announced that the 118th Annual General Meeting(AGM) of the company will be held on 12 August 2025.Powered by Capital Market - Live
5 months agoCapital Market - Live
Corporate
Board of Alembic recommends final dividend
Alembic announced that the Board of Directors of the Company at its meeting held on 13 May 2025, inter alia, have recommended the final dividend of Rs 2.4 per equity Share (i.e. 120%) , subject to the approval of the shareholders.Powered by Capital Market - Live
6 months agoCapital Market - Live
Earnings
Alembic consolidated net profit declines 5.13% in the March 2025 quarter
Net profit of Alembic declined 5.13% to Rs 68.45 crore in the quarter ended March 2025 as against Rs 72.15 crore during the previous quarter ended March 2024. Sales rose 22.90% to Rs 60.27 crore in the quarter ended March 2025 as against Rs 49.04 crore during the previous quarter ended March 2024. For the full year,net profit rose 15.66% to Rs 310.68 crore in the year ended March 2025 as against Rs 268.62 crore during the previous year ended March 2024. Sales rose 40.89% to Rs 221.89 crore in the year ended March 2025 as against Rs 157.49 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales60.2749.04 23 221.89157.49 41 OPM %45.3549.25 -42.2336.11 - PBDT29.6725.71 15 166.13110.53 50 PBT26.9224.23 11 155.50102.69 51 NP68.4572.15 -5 310.68268.62 16 Powered by Capital Market - Live
6 months agoCapital Market - Live
Corporate
Alembic to announce Quarterly Result
Alembic will hold a meeting of the Board of Directors of the Company on 13 May 2025.Powered by Capital Market - Live
7 months agoCapital Market - Live
Spotlight
Alembic Q3 PAT soars to Rs 26 cr
Profit before tax (PBT) was at Rs 27.39 crore in Q3 FY25, up 151.75% as against Rs 10.88 crore reported in the same period a year ago. Total expense jumped 13.79% year on year to Rs 34.90 crore during the quarter. Employee benefit expense stood at Rs 6.56 crore (up 17.56% YoY), while cost of materials consumed was at Rs 1.81 crore (up 14.56% YoY) during the period under review. The company's revenue from the active pharmaceutical ingredients business was at Rs 6.25 crore (down 3.55% YoY), while the real estate business came in at Rs 51.67 crore (up 57.29% YoY) during the period under review. On a 9-month basis, the net profit surged 68.8% to Rs 120.83 crore on a 49.04% rise in revenue from operations to Rs 161.62 crore in 9M FY25 over 9M FY24. Alembic is dealing in the Active Pharmaceutical Ingredient (API) Business and Real Estate Business. Shares of Alembic fell 1.69% to Rs 110.85 on the BSE.Powered by Capital Market - Live
9 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 12.14%, vs industry avg of 10.03%
Over the last 5 years, market share stayed at 0.07%
Over the last 5 years, net income has grown at a yearly rate of -1.15%, vs industry avg of 20.02%